Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single‐tablet regimen in a multicentre cohort in Spain-Reference-Cited by-同舟云学术

Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single‐tablet regimen in a multicentre cohort in Spain

Published:2021-07 Issue:7 Volume:24 Page:
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Int AIDS Soc

Author:

Suárez‐García Inés¹²^ORCID,Alejos Belén³,Ruiz‐Algueró Marta³,García Yubero Cristina⁴,Moreno Cristina³,Bernal Enrique⁵,Pérez‐Is Laura⁶,Zubero Zuriñe⁷,Zárraga Fernández Miguel Alberto⁸,Samperiz Abad Gloria⁹,Jarrín Inma³^ORCID,

Affiliation:

1. Infectious Diseases Group Department of Internal Medicine Hospital Universitario Infanta Sofía (FIIB HUIS HHEN) Madrid Spain

2. Universidad Europea Madrid Spain

3. National Epidemiology Centre Instituto de Salud Carlos III Madrid Spain

4. Department of Hospital Pharmacy Hospital Universitario Infanta Sofía (FIIB HUIS HHEN) Madrid Spain

5. Infectious Diseases Section Hospital General Universitario Reina Sofía Murcia Spain

6. FINBA/ISPA Hospital Universitario Central de Asturias Avilés Spain

7. Department of Infectious Diseases. Hospital Universitario Basurto Bizkaia Spain

8. Department of Internal Medicine Hospital San Agustín Avilés Spain

9. Infectious Diseases Unit Hospital Universitario Miguel Servet Zaragoza Spain

Funder

European Regional Development Fund

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.25758

Reference32 articles.

1. Survival of Persons with and without HIV Infection in Denmark, 1995–2005

2. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

3. Newer drugs and earlier treatment

4. The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States

5. Ruiz‐AlgueróM Suárez‐GarcíaI Álvarez del ArcoD LázaroP MorenoS JarrínI.Uso de recursos sanitarios y costes asociados al tratamiento antirretroviral de primera línea en España en la era de los inhibidores de la integrasa Pharm Care.2019;21(2).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line antiretroviral therapy initiation for newly diagnosed people with HIV in the Netherlands: A retrospective analysis from 2016 to 2020;PLOS ONE;2024-07-26

2. Prescriptions of generic antiretroviral drugs in three healthcare centers in the Paris area, France;AIDS;2024-05-30

3. Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimen;AIDS;2024-04-20

4. Use of Generic Antiretroviral Drugs and Single-Tablet Regimen De-Simplification for the Treatment of HIV Infection in Spain;AIDS Research and Human Retroviruses;2022-06-01